Cell-based approaches advancing to meet challenges of corneal regeneration

LOS ANGELES — Tissue engineering-based therapy holds great promise for the future of corneal regeneration and reconstruction.“Replacing live with live” is the goal, Damien Harkin, MD, said at Cornea Subspecialty Day preceding the American Society of Cataract and Refractive Surgery meeting.

Full Story →